Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Pfizer-Lilly’s tanezumab reduces chronic low back pain in trial

Trial evaluated subcutaneous administration of tanezumab for 16 weeks. Credit: ZaldyImg.



  • Pfizer-Lilly’s tanezumab reduces chronic low back pain in Phase III trial

Go Top